Chemic, Gateway Analytical in Joint Analytics Collaboration

Chemic Laboratories and Gateway Analytical have entered a Joint Cooperation Agreement for one year to collaborate on a variety of pharma and biopharma client interests, primarily in the areas of product development as it pertains to extractables, leachables, visible and sub-visible particulate analysis supporting Single-Use Systems (SUS). The companies will leverage their collective analytics expertise to help improve clients business performance and provide a greater understanding of their materials of choice.
 
Each company will offer each other’s services and direct access to technical subject matter experts. Chemic and Gateway will utilize chromatographic, spectroscopic and microscopic analytics to provide extractable and particulate matter data assessing material compatibility and suitability for biopharma use. According to the companies, developing detailed informational packages will allow SUS users to streamline their processes, predict material compatibility, and evaluate product /process risk.
 
“Chemic is very pleased to establish this formal working relationship with Gateway, which is an established expert in the field of particulate analysis and identification,” said Joseph St. Laurent, president and chief scientific officer of Chemic Laboratories. “This Joint Agreement allows our two companies to immediately leverage our particular expertise for the advancement of SUS in the biopharmaceutical marketplace.”
 
“Gateway Analytical is proud to announce our collaboration with Chemic Laboratories,” said David Exline, senior vice president at Gateway Analytical. “We recognize that drug manufacturers often need analytical support at many different levels, and this agreement allows us to offer a more comprehensive range of solutions and expertise in both common and specialized areas. We see excellent benefits for our clients and mutual business objectives by working with Chemic.”